Soft tissue regeneration biotech Aroa Biosurgery has boosted annual sales and narrowed its loss, but expects losses to continue as it invests in the US and new products.
The Auckland-based, ASX-listed company brought in product revenue in the year to March 31 of $39.2 million, up 81% on 2021. (On a
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
